Turkish Journal of Medical Sciences
Volume 49

Number 2

Article 8

1-1-2019

Reference ranges for serum immunoglobulin (IgG, IgA, and IgM)
and IgG subclass levels in healthy children
RUMEYSA OLCAY BAYRAM
HÜLYA ÖZDEMİR
AYÇA EMSEN
HATİCE TÜRK DAĞI
HASİBE ARTAÇ

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
BAYRAM, RUMEYSA OLCAY; ÖZDEMİR, HÜLYA; EMSEN, AYÇA; DAĞI, HATİCE TÜRK; and ARTAÇ, HASİBE
(2019) "Reference ranges for serum immunoglobulin (IgG, IgA, and IgM) and IgG subclass levels in
healthy children," Turkish Journal of Medical Sciences: Vol. 49: No. 2, Article 8. https://doi.org/10.3906/
sag-1807-282
Available at: https://journals.tubitak.gov.tr/medical/vol49/iss2/8

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Turkish Journal of Medical Sciences

Turk J Med Sci
(2019) 49: 497-505
© TÜBİTAK
doi:10.3906/sag-1807-282

http://journals.tubitak.gov.tr/medical/

Research Article

Reference ranges for serum immunoglobulin (IgG, IgA, and IgM) and
IgG subclass levels in healthy children
1

1

1

2

1,

Rumeysa Olcay BAYRAM , Hülya ÖZDEMIR , Ayça EMSEN , Hatice TÜRK DAĞI , Hasibe ARTAÇ *
1
Department of Pediatric Immunology and Allergy, Faculty of Medicine, Selçuk University, Konya, Turkey
2
Department of Medical Microbiology, Faculty of Medicine, Selçuk University, Konya, Turkey
Received: 30.07.2018

Accepted/Published Online: 20.01.2019

Final Version: 18.04.2019

Background/aim: The serum immunoglobulin levels are used routinely in clinical practice because they provide key information on
the humoral immune status. This study aimed to determine the age-related reference values of serum immunoglobulin levels in healthy
children.
Materials and methods: A total of 330 healthy children, aged between 0 and 18 years, were included in this study. The serum
immunoglobulin levels were measured using a nephelometric method in a total of 11 groups, each group consisting of 30 individuals,
and IgG subclasses in 6 groups of children aged more than 2 years.
Results: The serum IgG levels were high during the newborn period, decreased until the sixth month, and again increased to a maximum
level at the age of 18 years. The level of IgA was found to be extremely low in the newborn period and then increased with age. While the
lowest value was in the newborn period for serum IgM level, the highest value was in the 16- to 18-year-old period. The IgG subclasses
varied depending on the age groups.
Conclusion: The updated reference intervals of immunoglobulin levels in children may be used for the accurate diagnosis of immune
deficiencies.
Key words: Healthy children, IgG subclasses, reference interval, serum immunoglobulins

1. Introduction
The serum immunoglobulin levels are the most important
screening tests for determining primary and secondary
immunodeficiencies (1). They are also important in
evaluating different clinical conditions such as autoimmune
diseases and chronic liver diseases (2,3). Reference ranges
according to age for immunoglobulins (IgG, IgA, and IgM)
and IgG subclass concentrations (IgGSc) vary depending
on the region, source population, applied method, and
time. For this reason, these values need to be updated for
an accurate diagnosis in the same ethnic group and same
region.
Primary immune deficiencies form a group of more
than 350 diseases that affect the development and/or
function of the immune system and are characterized
by susceptibility to infections, autoimmune diseases and
malignancy, and inherited gene defects. They are classified
into nine different groups according to the component
of the immune system that they affect (4). In pediatric
clinical practice, severe, persistent, opportunistic or

recurrent infections are the most frequent indication
for determination of serum immunoglobulin levels.
The knowledge of immunoglobulin isotype provides
useful insight into complex humoral immune response.
The antibody deficiencies are the most common types
of the primary immunodeficiencies. According to the
European Society for Immunodeficiencies, the proportion
of antibody deficiencies accounts for about 60% of all
primary immunodeficiencies (5). This rate was found to
be 73% in Turkey and 92% in the province of Konya in
previous studies (6,7).
The initial laboratory examination of humoral
immunity consists of measuring levels of various
immunoglobulin isotypes (IgG, IgA, IgM, and possibly
IgGSc) in serum and comparison with values from
normal age-matched controls. The assessment is clinically
important when they are within the normal age-specific
reference range. Because of the limited number of studies
(8–10) and the necessity of an update, this study aimed
to determine reference intervals in healthy children by
measuring the levels of serum immunoglobulin and IgGSc.
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2. Materials and methods
2.1. Study population
A total of 330 children without any diseases, between the
ages of 0 and 18 years, were included in the study. During
the first step for the study, serum samples of 540 healthy
children were collected after written informed consent was
obtained from all their parents. A form, which included
information on sex, height, weight, date of birth, age at the
time of admission, address and telephone information, the
history of immune deficiency, allergic and chronic diseases
was filled out. Of these serum samples collected over a
2-year period, 210 of the participants were removed from
the study due to recurrent infections and various reasons
including allergic, rheumatological, and gastrointestinal
diseases detected during the children’s follow-up. Healthy
children were divided into 11 groups according to age as
follows: 30 newborns between 0 and 1 month; 30 children
each between 1 and 3 months, 4 and 6 months, 7 and 12
months, 13 and 24 months, 25 and 36 months, 3 and 5
years, 6 and 8 years, 9 and 11 years, and 12 and 16 years,
and 16 and 18 years. The serum immunoglobulin levels
were measured using a nephelometric method in a total
of 11 groups, each group consisting of 30 individuals, and
IgG subclasses in 6 groups of children aged more than 2
years. This study was approved by the Ethical Committee
of Selçuk University Medical Faculty.
2.2. Laboratory analysis
The levels of serum IgA, IgG, IgM, and IgG1, IgG2,
IgG3, IgG4 were measured by the nephelometric method
using the IMMAGE 800 device (Beckman Coulter, Inc.,
Brea, CA, USA). The values of serum immunoglobulin
and IgG subgroup levels were expressed in mg/dL. The
IMMAGE Immunochemistry Systems kits for IgA, IgG,
and IgM and the kits for the IMMAGE 800 device (The
Binding Site Group Ltd., UK) for the IgGSc were used.
For measuring IgA, IgG, and IgM parameters (IMMAGE
Immunochemistry Systems, Chemistry References,
Beckman Coulter, Inc.) and IgGSc (The Binding Site Ltd.),
an internal quality control study was performed using two
levels of control serum. An international interlaboratory
comparison program (RIQAS International Quality
Assessment Scheme, UK) was followed for the external
quality control.
2.3. Statistical analysis
SPSS for Windows 15.0 was used for statistical analyses.
While the IgG, IgA, and IgM values were examined for
the groups after 1–30 days, 1–3 months, 4–6 months,
7–12 months, 13–24 months, 25–36 months, 3–5 years,
6–8 years, 9–11 years, 12–16 years, and 16–18 years; the
IgG1, IgG2, IgG3, and IgG4 values were measured for the
groups 25–36 months, 3–5 years, 6–8 years, 9–11 years,
12–16 years, and 16–18 years. Descriptive statistics, such
as geometric mean, arithmetic mean, minimum, and
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maximum values, and mean ± 2 standard deviation values
for each age group, were given. A 95% confidence interval
was also established for each age group.
The data were divided into subgroups according to
sex and age group. The difference between the age groups
and sex (IgG, IgA, IgM, IgG1, IgG2, IgG3, and IgG4) was
investigated. When comparing the differences between
the two groups, the t-test was used in independent groups
showing normal distribution and the Mann–Whitney U
test was used for abnormal distribution. When comparing
the mean between more than two groups, the one-way
analysis of variance (ANOVA) was used for normal
distribution and the Kruskal–Wallis test was used for the
abnormal distribution. The significance level was accepted
as P < 0.05.
3. Results
In this study, 177 of 330 patients were male and 153 were
female. When serum immunoglobulins and IgGSc were
evaluated according to sex, the serum IgM and IgG2 levels
were higher in females (P = 0.004 and 0.011, respectively).
The serum IgM levels were significantly different at the age
groups including 1–30 days, 6–8 years, and 12–16 years (P
= 0.04, P = 0.002 and P = 0.01, respectively). The serum
IgG2 levels were higher in females at the age of 6–8 years
and 16–18 years (P = 0.04 and P = 0.003, respectively). No
significant difference in IgG, IgA, IgG1, IgG3, and IgG4
was observed between boys and girls (Table 1).
The difference in the IgG, IgA, IgM, and IgGSc
according to age was statistically analyzed using the
ANOVA and Kruskal–Wallis tests (Table 2). The geometric
mean, arithmetic mean, standard deviation, minimum
and maximum values, and 95% confidence intervals for
the serum IgG, IgA, IgM, and IgGSc concentrations are
shown in Tables 3–9.
3.1. Serum immunoglobulin levels (IgG, IgA, IgM)
Age-related changes in the serum IgG, IgA, and IgM (the
5%, 50%, 95% percentile ranges) are shown in Figure
1. According to age groups, the serum IgG levels were
found to be high in the newborn period (0–30 days) due
to maternal IgG. These parameters were the lowest level
due to loss of antibodies from the mother and inadequate
synthesis in the second and third groups (1–6 months).
Starting from the 6th month, the serum IgG levels
increased, reaching maximum values at 16–18 years of age
(Table 3).
No significant difference was detected according to
age for serum IgA levels. Although the IgA levels were
very low during the neonatal period, they increased with
age and reached their maximum value at the age of 18
years (Table 4).
The IgM levels increased steadily after neonatal period
but were low slightly in the 25- to 36-month group and
after 6 years of age until the age of 11 years compared to the
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Table 1. Examination of variables according to sex.
Variable

Test

P-value

Mean ± SD

IgG

t-test

0.673

No difference

IgA

Mann–Whitney U test

0.567

No difference

IgM

t-test

0.004

Difference present; higher in girls (1–30 days, 6–8 years and 12–16 years)*

IgG1

t-test

0.471

No difference

IgG2

Mann–Whitney U test

0.011

Difference present; higher in girls (6–8 years and 16–18 years)*

IgG3

Mann–Whitney U test

0.066

No difference

IgG4

Mann–Whitney U test

0.186

No difference

IgG: Immunoglobulin G, IgA: Immunoglobulin A, IgM: Immunoglobulin M
* The difference in the serum IgM and IGG2 levels according to sex was detected in these age groups.
Table 2. Examination of variables according to age.
Variable

Test

P-value

Decision

IgG

ANOVA

0.000

Difference present (it increased with age, except for the 0- to 1-month age group; the
highest value was found in the 16- to 18-year age range)

IgA

Kruskal–Wallis test

0.567

No difference

IgM

ANOVA

0.000

Difference present (while the highest value was found in the 16- to 18-year age
range, the lowest was found in the 0- to 1-month age group)

IgG1

ANOVA

0.000

Difference present (while the highest value was found in the 16- to 18-year age
range, the lowest was found in the 3- to 5-year age group)

IgG2

Kruskal–Wallis test

0.011

Difference present (the value increased with age)

IgG3

Kruskal–Wallis test

0.066

No difference

IgG4

Kruskal–Wallis test

0.186

No difference

ANOVA: Analysis of variance
IgG; Immunoglobulin G, IgA: Immunoglobulin A, IgM: Immunoglobulin M
Table 3. Age-related serum IgG levels in healthy children (mg/dL).
Age group

Number

Geometric mean ± SD

Mean ± SD

Min–max

95% confidence interval

0–30 days

30

913.85 ± 262.19

953 ± 262.19

399–1480

855.1–1050.9

1–3 months

30

409.86 ± 145.59

429.5 ± 145.59

217–981

375.14–483.86

4–6 months

30

440.17 ± 236.8

482.43 ± 236.8

270–1110

394.01–570.86

7–12 months

30

536.79 ± 186.62

568.97 ± 186.62

242–977

499.28–638.65

13–24 months

30

726.79 ± 238.61

761.7 ± 238.61

389–1260

672.6–850.8

25–36 months

30

786.41 ± 249.14

811.5 ± 249.14

486–1970

718.47–904.53

3–5 years

30

823.19 ± 164.19

839.87 ± 164.19

457–1120

778.56–901.18

6–8 years

30

982.86 ± 255.53

1014.93 ± 255.53

483–1580

919.52–1110.35

9–11 years

30

1016.12 ± 322.27

1055.43 ± 322.27

642–2290

935.09–1175.77

12–16 years

30

1123.56 ± 203.83

1142.07 ± 203.83

636–1610

1065.96–1218.18

16–18 years

30

1277.20 ± 361.89

1322.77 ± 361.89

688–2430

1187.63–1457.9

Total

330

773.94 ± 361.76

852.92 ± 361.76

217–2430

813.75–892.1

IgG: Immunoglobulin G
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Figure 1. Percentile ranges of the serum IgG, IgA and IgM levels.

Table 4. Age-related serum IgA levels in healthy children (mg/dL).
Age group

Number

Geometric mean ± SD

Mean ± SD

Min–max

95% confidence interval

0–30 days

30

6.77 ± 0.45

6.79 ± 0.45

6.67–8.75

6.62–6.95

1–3 months

30

9.58 ± 5.16

10.53 ± 5.16

6.67–24.6

8.57–12.49

4–6 months

30

17.23 ± 9.77

19.86 ± 9.77

6.67–53

14.70–25.01

7–12 months

30

23.63 ± 12.37

29.41 ± 12.37

6.68–114

21.06–37.77

13–24 months

30

34.09 ± 17.1

37.62 ± 17.1

13.1–103

31.34– 47.85

25–36 months

30

48.87 ± 24.52

59.77 ± 24.52

6.67–135

46.05–71.38

3–5 years

30

62.75 ± 34.05

68.98 ± 34.05

35.7–192

56.27–81.7

6–8 years

30

97.38 ± 49.66

106.9 ± 49.66

44.8–276

88.36–125.45

9–11 years

30

102.27 ± 47.05

115.99 ± 47.05

32.6–262

94.69–137.29

12–16 years

30

112.16 ± 47.51

120.90 ± 47.51

36.4–305

99.29–172.11

16–18 years

30

179.21 ± 89.92

201.84 ± 89.92

46.3–385

168.26– 235.41

Total

330

41.04 ± 32.13

70.78 ± 32.13

6.67–385

64.07–80.54

IgA: Immunoglobulin A
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other age groups. After the age of 11 years, they increased
again and reached their maximum value in the 16 to 18
year age group (Table 5).
3.2. Serum immunoglobulin G subclass levels (IgG1,
IgG2, IgG3, IgG4)
The 5%, %50, and %95 percentile ranges (in increasing
order to levels in the graphs) for the IgG subclasses are
shown in Figure 2. According to age, the highest value was
in the 16 to 18 years of age range for serum IgG1 level,
while the lowest value was in the 3 to 4 years of age. The
serum IgG2 values increased with age. No statistically
significant difference was observed in the serum IgG3 and
IgG4 levels according to age (Tables 6–9).
The IgG1 levels were the lowest in the 25- to 36-month
group and increased after 36 months until the age of 9
years. A second decline was seen in the 9- to 11-year age
group, and another increase was seen at the age of 12–16
years. After the age of 16 years, they reached the adult level
with a third decline (Table 6).
The IgG2 levels increased from the 25th month onward
and reached maximum values at the age of 16–18 years
(Table 7).
The IgG3 levels showed a partial decline at the age of
6–8 years and then continued to increase steadily. The
levels reached a maximum value at the age of 16–18 years
(Table 8).
Although the IgG4 levels showed fluctuations at the
age of 2–11 years, they continued to increase after the age
of 11 years and reached the maximum values in the 16- to
18-year age group (Table 9).

4. Discussion
The first stage in evaluating possible underlying
immunodeficiency is the measurement of blood count
and serum immunoglobulin levels (11). The standards
for changes in antibody production by age during
childhood vary according to different ethnic groups and
settlement regions. Hence, the immunoglobulin levels
should be compared with age-appropriate reference values
according to the 95% confidence interval. In this study,
the distribution of serum immunoglobulins and IgGSc
according to age and sex were examined in children and
the reference intervals were determined.
In the present study, the serum IgG levels were
extremely high in the newborn period due to the IgG
passed on from the mother. These parameters fell to the
lowest level due to loss of antibodies from the mother
and inadequate synthesis in the baby in the second and
third groups (1–6 months). Again, the serum IgG levels
increased with age, starting from the 6th month, reaching
maximum values at 16–18 years of age. However, the IgA
levels were extremely low in the newborn period and
increased with age, reaching their maximum values at the
age of 18 years. These results were compatible with the
findings of studies conducted in Turkey and quoted in
the literature (8–10, 12). The IgM levels did not show a
continuous increase in our study, contrary to the previous
studies (8–10, 12). The continuous increase seen in the
1st month fluctuated till 2 years of age. Low values were
determined in the 25- to 36-month group, and then from
the ages of 6 years until 11 years. After the age of 11 years,

Table 5. Age-related serum IgM levels in healthy children (mg/dL).
Age group

Number

Geometric mean ± SD

Mean ± SD

Min–max

95% confidence interval

0–30 days

30

16.89 ± 8.87

20.38 ± 8.87

5.1–50.9

15.57–5.18

1–3 months

30

34.21 ± 13.55

36.66 ± 13.55

15.2–68.5

31.60–41.72

4–6 months

30

69.05 ± 29.73

75.44 ± 29.73

26.9–130

64.34–86.54

7–12 months

30

73.42 ± 35.76

81.05 ± 35.76

24.2–162

67.7–94.41

13–24 months

30

115.25 ± 41.63

122.57 ± 41.63

38.6–195

107.03–138.12

25–36 months

30

104.66 ± 40.55

111.31 ± 40.55

42.7–236

96.17–126.46

3–5 years

30

115.60 ± 39.24

121.79 ± 39.24

58.7–198

107.13–136.44

6–8 years

30

108.05 ± 41.27

114.73 ± 41.27

50.3–242

99.32–130.14

9–11 years

30

104.95 ± 43.68

113.18 ± 43.68

37.4–213

96.87–129.49

12–16 years

30

119.16 ± 39.31

125.78 ± 39.31

42.4–197

111.1–140.46

16–18 years

30

130.60 ± 64.32

142.54 ± 64.32

60.7–323

118.53–166.55

Total

330

78.74 ± 43.46

96.86 ± 43.46

5.1–323

91.07–102.65

IgM: Immunoglobulin M
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Figure 2. Percentile ranges of the serum IgG subclasses (IgG1, IgG2, IgG3 and IgG4) levels.
Table 6. Age-related serum IgG1 levels in healthy children (mg/dL).
Age group

Number

Geometric mean ± SD

Mean ± SD

Min–max

95% confidence interval

25–36 months

30

510.74 ± 192.04

531.7 ± 192.04

309–1450

459.98–603.41

3–5 years

30

506.73 ± 82.28

513.93 ± 82.28

273–679

483.20–544.65

6–8 years

30

567.94 ± 121.64

581 ± 121.64

292–781

535.87– 626.72

9–11 years

30

634.17 ± 216.39

660.23 ± 216.39

410–153

579.43–741.03

12–16 years

30

635.52 ± 131.01

648.53 ± 131.01

344–958

599.61–697.45

16–18 years

30

645.35 ± 229.62

674.5 ± 229.62

403–1520

588.75–760.24

Total

180

580.41 ± 179.97

601.7 ± 179.97

273–1530

575.22–628.17

IgG1: Immunoglobulin G1

they increased again and reached their maximum value in
the age group of 16 to 18 years.
Previous studies explored the normal values of
immunoglobulin levels which obtained by different
methods, such as enzyme-linked immunosorbent
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assay (ELISA), radioimmunoassay, turbidimetry, and
nephelometry, in children and adults (12–14). The
International Federation of Clinical Chemistry and
Laboratory suggests that each laboratory should calculate
its own reference values and publish, together with the
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Table 7. Age-related serum IgG2 levels in healthy children (mg/dL).
Age group

Number

Geometric mean ± SD

Mean ± SD

Min–max

95% confidence interval

25–36 months

30

137.88 ± 38.59

141.98 ± 38.59

87.6–289

127.57–156.39

3–5 years

30

143.92 ± 50,802

151.95 ± 50.80

73.3–271

132.98–170.92

6–8 years

30

196.57 ± 86.41

213.67 ± 86.41

88.1–408

181.40– 245.93

9–11 years

30

250.67 ± 85.72

265.56 ± 85.72

81–442

233.55–297.57

12–16 years

30

261.62 ± 69,147

270.23 ± 69.14

159–406

244.41–296.05

16–18 years

30

359.76 ± 115,839

375.9 ± 115.83

184–696

332.6–419.15

Total

180

212.48 ± 111,265

236.55 ± 111.26

73.3–696

220.18–252.91

IgG2: Immunoglobulin G2
Table 8. Age-related serum IgG3 levels in healthy children (mg/dL).
Age group

Number

Geometric mean ± SD

Mean ± SD

Min–max

95% confidence interval

25–36 months

30

48.78 ± 16.90

51.73 ± 16.90

19.8–75

45.41–58.04

3–5 years

30

44.05 ± 21.55

45.26 ± 21.55

20.8–93.2

37.21–53.30

6–8 years

30

56.82 ± 30.55

65.53 ± 30.55

18.9–135

53.01–78.06

9–11 years

30

77.59 ± 37.37

84.19 ± 37.37

34.1–200

70.24–98.15

12–16 years

30

75.30 ± 31.86

81.39 ± 31.86

35.2–150

69.49–93.28

16–18 years

30

86.33 ± 43.29

95.12 ± 43.29

29.3–200

78.95–111.28

Total

180

62.72 ± 37.13

70.53 ± 30.13

18.9–200

65.19–75.837

IgG3: Immunoglobulin G3
Table 9. Age-related serum IgG4 levels in healthy children (mg/dL).
Age group

Number

Geometric mean ± SD

Mean ± SD

Min–max

95% confidence interval

25–36 months

30

15.53 ± 8.54

18.37 ± 8.54

7.86–57.5

13.67–23.07

3–5 years

30

30.81 ± 15.42

40.75 ± 15.42

7.86–122

28.84–52.65

6–8 years

30

39.33 ± 23.05

50.94 ± 23.05

7.86–157

37.11–64.77

9–11 years

30

25.36 ± 15.39

35.51 ± 15.39

7.86–93.8

24.95–46.07

12–16 years

30

31.03 ± 16.73

39.51 ± 16.73

7.86–119

29.53–49.49

16–18 years

30

38.89 ± 23.08

50.16 ± 23.08

7.86–157

36.32–64.01

Total

180

28.71 ± 15.76

39.21 ± 157.66

7.86–157

34.56–43.86

IgG4: Immunoglobulin G4

National Committee for Clinical Laboratory Standard,
guiding standards for laboratories (15). Studies on
reference intervals of serum immunoglobulins and
IgGSc, which were used in the diagnosis and follow-up of
various immunological diseases, demonstrated that these
values changed depending on the methods used, patient
population, age, and sex. The inconsistencies seen in
some of the earlier studies might be due to the method of
analysis. In the earlier studies, the serum immunoglobulins

and IgGSc were measured using radial immunodiffusion,
which was then changed with a method developed based
on ELISA using monoclonal antibodies. Nowadays, the
nephelometric measurement method, which is faster and
has less variability, is more commonly used (14,16). In the
present study, the immunoglobulin levels were measured
by the nephelometric method.
The first study performed on this subject in Turkey was
in 1996 in Ankara, where the normal values of the IgG, IgA,
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and IgM levels were determined using the turbidimetric
method. The serum IgG fell to 39% of the adult level after
31 days. It was 52% at the age of 1 year, increased to 97% of
the adult level at the age of 7 years, and elevated above the
adult level between the ages of 11 and 16 years (8). Tezcan
et al. observed a continuous increase in the IgM levels in
the 1st month, reaching close to the adult level at early ages.
Between the ages of 13 and 16 years, the levels reached the
adult levels. Although the IgA levels were extremely low
during the neonatal period, they increased with age and
passed 90% of the adult level at the age of 13 years. These
results were consistent with the findings of our study.
The second study was conducted in 2006 by Aksu et
al. using the nephelometric method, and the reference
ranges of IgG, IgA, IgM, and IgGSc were determined. In
that study, the levels of serum IgG and IgGSc were higher
in the newborn period (0–30 days) due to maternal IgG.
In children in the second group (1–5 months), these
parameters fell to the lowest level due to loss of antibodies
from the mother and inadequate synthesis in the baby. After
the 6th to 8th month, an increase in immunoglobulins
and IgGSc according to age was observed. The IgG, IgA,
IgG1, and IgG2 levels increased until the age of 9–10 years,
and then reached a plateau. The IgG3 and IgG4 levels
increased up to the ages of 7–8 years and then reached
a plateau. The IgM levels increased earlier and reached a
balanced value after the first year of life (9). In our study,
all immunoglobulin levels increased with age and no
plateau was observed.
The third study was carried out in İzmir in 2010 using
the nephelometric method, and the reference ranges of
IgG, IgA, IgM, and IgGSc were determined. In females, the
reference intervals of all tests were found to be higher in
females compared with males (10). No newborn separation
was done, and neonates were evaluated after 0–6 months.
In that study, the IgG values in the 95% confidence interval
were found to be lower in the first 12 months and then
increased in the later age groups. This might be due to the
fact that fewer data were available on the age groups in that
study and statistical analysis was lacking.
The IgG subclass deficiencies are defined as one or both
of the IgGSc below normal values according to age, while
the IgG, IgA, and IgM values are normal. Studies have
shown that IgG1 and IgG3 levels reach 75% of the adult
level at 5 years of age. The level of IgG2 reaches 75% of the
adult level at 14 years of age. However, the normal limits
of IgG4 could not be fully determined and IgG4 deficiency
should not be diagnosed under the age of 10 years (1). In
our study, the level of IgG1 reached 76% of the 16- to 18year age group values at the age of 3–5 years, and the level
of IgG2 reached approximately 70% of the 16- to 18-year
age group level between 9 and 11 years of age and the level
of IgG3 between the ages of 6 and 8 years. The level of
IgG4 the 3- to 5-year age group reached 80% of the biggest
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childhood age group. IgG4 is a blocking antibody and does
not bind to its complement. Its level decreases in allergic
diseases and increases with allergen immunotherapy. We
observed that the adult levels can be reached earlier in
the population used in this study. It is also important for
determining the upper limits that regulate IgG4-related
diseases.
Several studies have reported IgGSc in healthy children
and adults (17,18). We observed the IgG1, IgG2, and
IgG3 levels increased with age. The maximum reference
values for all IgGSc were reached in the 16- to 18-year age
group. The results were broadly similar to those reported
in previous studies. Fluctuations in IgG4 levels were
observed between the age groups in our study, whereas
IgG4 concentrations continued to increase with age in
some studies (18). Our results are similar to the findings
of a Thai study (19).
The present study had some limitations. Our population
included healthy children who live in Konya and therefore
the selected samples may not totally reflect the Turkish
population. However, Konya is a big city in the Central
Anatolia including admixture of Turkish children, so we
think that the updated reference values may be used in
Turkey. The relatively small study population may reduce
the power of the study and the national database is needed
for serum immunoglobulin levels in a larger Turkish
population.
In conclusion, the present study provided usable
data on normal values and age-related changes in serum
immunoglobulins and IgGSc. It constituted a step in
establishing a reliable reference source for laboratories. It
made an important contribution, especially in determining
the reference values of regional immunoglobulins and
IgGSc, for the childhood age group. Previous studies
suggested that issues, such as difficulties encountered in
identifying reference individuals, limitations of small
laboratories, and standardization of regional and biological
variations, need to be resolved with multicentered and
national reference policies. A healthy regional database
should be maintained with the participation of larger sample
groups and by continuing these studies. The reference
values for serum immunoglobulin levels and IgGSc in
healthy children were updated with this study. Autosomal
recessive inherited primary immune deficiencies are
common in Turkey with high rates of consanguineous
marriages. This study is important in terms of being a
reference source for assessing immunoglobulin levels for
accurate diagnosis, treatment, and follow-up of primary
and secondary immunodeficiencies in children.
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